Calcinosis Cutis Complicated with Recurrent Tissue Infections in a Patient with Limited Cutaneous Systemic Sclerosis: A Case Report

Main Article Content

Roberto de Jesús Martínez Camacho
Lilia Itzel Martínez Camacho
Daira Martínez Camacho
Hector Murillo Reyna
Ania Martínez Camacho

Abstract

Calcinosis related to systemic sclerosis is a debilitating vascular complication that negatively affects quality of life. It results from the deposition of calcium hydroxyapatite in soft tissues that occurs in the presence of normal calcium and phosphorus metabolism. Injuries can be painful and cause tissue inflammation, ulcers with infections, or deformities that cause functional disability.


We present the case of a 29-year-old woman with a history of calcinosis cutis associated with systemic sclerosis, lesions complicated by soft tissue infections, leading to septic arthritis. During the approach, improvement was achieved with the use of intravenous antibiotics and a long oral regimen. As it is a disease without definitive treatment, we improve the patient's living conditions and prevent future infections with non-pharmacological therapeutic measures.

Article Details

How to Cite
Martínez Camacho, R. de J., Martínez Camacho, L. I. ., Martínez Camacho, D., Murillo Reyna, H., & Martínez Camacho, A. . (2023). Calcinosis Cutis Complicated with Recurrent Tissue Infections in a Patient with Limited Cutaneous Systemic Sclerosis: A Case Report. International Journal of Medical Science and Clinical Research Studies, 3(12), 3113–3117. https://doi.org/10.47191/ijmscrs/v3-i12-34
Section
Articles

References

I. Elahmar H, Feldman BM, Johnson SR. Management of Calcinosis Cutis in Rheumatic Diseases. J Rheumatol. 2022 Sep;49(9):980-989. doi: 10.3899/jrheum.211393. Epub 2022 May 15.

II. Saketkoo LA, Gordon JK, Fligelstone K, Mawdsley A. Patient Experience of Systemic Sclerosis-Related Calcinosis: An International Study Informing Clinical Trials, Practice, and the Development of the Mawdsley Calcinosis Questionnaire. Rheum Dis Clin North Am. 2023 May;49(2):463-481. doi: 10.1016/j.rdc.2023.01.017.

III. Davuluri S, Lood C, Chung L. Calcinosis in systemic sclerosis. Curr Opin Rheumatol. 2022 Nov 1;34(6):319-327. doi: 10.1097/BOR.0000000000000896. Epub 2022 Aug 19.

IV. Valenzuela A, Song P, Chung L. Calcinosis in scleroderma. Curr Opin Rheumatol. 2018 Nov;30(6):554-561. doi: 10.1097/BOR.0000000000000539.

V. Cruz-Domínguez MP, García-Collinot G, Saavedra MA, Medina G, Carranza-Muleiro RA, Vera-Lastra OL, Jara LJ. Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol. 2017 Jan;36(1):111-117. doi: 10.1007/s10067-016-3412-9. Epub 2016 Oct 7.

VI. Le C, Bedocs PM. Calcinosis Cutis. [Updated 2023 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK448127/

VII. Boettler MA, Kaffenberger BH, Chung CG. Cellulitis: A Review of Current Practice Guidelines and Differentiation from Pseudocellulitis. Am J Clin Dermatol. 2022 Mar;23(2):153-165. doi: 10.1007/s40257-021-00659-8. Epub 2021 Dec 13.

VIII. Valenzuela A, Chung L. Subcutaneous calcinosis: Is it different between systemic sclerosis and dermatomyositis? J Scleroderma Relat Disord. 2022 Feb;7(1):7-23. doi: 10.1177/23971983211053245. Epub 2021 Oct 28.

Most read articles by the same author(s)